FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (78 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1078.931/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931
Version 20240709
Status active
Date 2024-07-09T01:07:16-04:00
Name LiraglutideMeds
Title Liraglutide meds
Experimental False
Realm us
Authority hl7
Purpose (Clinical Focus: Medications containing liraglutide, including combination medications and medications with indications other than type 2 diabetes mellitus.),(Data Element Scope: RxCUIs at product level (SCD, GPCK, SBD, BPCK)),(Inclusion Criteria: Valid, prescribable RxCUIs (including retried RxCUIs) with liraglutide as ingredient),(Exclusion Criteria: Invalidated RxCUIs)

Resources that use this resource

ValueSet
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.933 T2DM meds benefitting ASCVD
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.934 T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.935 T2DM meds benefitting CKD stage 5

Resources that this resource uses

CodeSystem
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm


Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1078.931",
  "meta" : {
    "versionId" : "7",
    "lastUpdated" : "2024-07-09T01:07:16.000-04:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "Optum Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-07-09"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2024-07-09"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.931",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1078.931"
    }
  ],
  "version" : "20240709",
  "name" : "LiraglutideMeds",
  "title" : "Liraglutide meds",
  "status" : "active",
  "date" : "2024-07-09T01:07:16-04:00",
  "publisher" : "Optum Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: Medications containing liraglutide, including combination medications and medications with indications other than type 2 diabetes mellitus.),(Data Element Scope: RxCUIs at product level (SCD, GPCK, SBD, BPCK)),(Inclusion Criteria: Valid, prescribable RxCUIs (including retried RxCUIs) with liraglutide as ingredient),(Exclusion Criteria: Invalidated RxCUIs)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1598268",
            "display" : "3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]"
          },
          {
            "code" : "1860167",
            "display" : "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector"
          },
          {
            "code" : "1860172",
            "display" : "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector [Xultophy]"
          },
          {
            "code" : "897122",
            "display" : "3 ML liraglutide 6 MG/ML Pen Injector"
          },
          {
            "code" : "897126",
            "display" : "3 ML liraglutide 6 MG/ML Pen Injector [Victoza]"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:17e75a15-2fcb-4ea2-8f18-1fa458253736",
    "timestamp" : "2024-12-10T05:58:41-05:00",
    "total" : 5,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1598268",
        "display" : "3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1860167",
        "display" : "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1860172",
        "display" : "3 ML insulin degludec 100 UNT/ML / liraglutide 3.6 MG/ML Pen Injector [Xultophy]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "897122",
        "display" : "3 ML liraglutide 6 MG/ML Pen Injector"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "897126",
        "display" : "3 ML liraglutide 6 MG/ML Pen Injector [Victoza]"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.